SCHEMBL844236

SCHEMBL844236

O=[N+]([O-])c1cccc(Cl)c1CBr

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.51
KDM4E B2RXH2 2/20 0.51
LMNA P02545 2/20 0.48
HPGD P15428 2/20 0.46
TDP1 Q9NUW8 4/20 0.45
MAPT P10636 3/20 0.45
MAPK1 P28482 2/20 0.45
POLB P06746 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.44
GPR35 Q9HC97 1/20 0.44
TSHR P16473 1/20 0.43
CYP2C19 P33261 3/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2C9 P11712 2/20 0.43
CYP3A4 P08684 2/20 0.43
CYP2D6 P10635 2/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31148323 1.00 ALDH1A1 (0.51) ALDH1A1KDM4ELMNAHPGDTDP1
SCHEMBL3420889 0.86 TDP1 (0.54) ALDH1A1KDM4EHPGDTDP1MAPT
SCHEMBL5739265 0.86 ALDH1A1 (0.52) ALDH1A1KDM4ELMNAHPGDTDP1
SCHEMBL10756135 0.83 ALDH1A1 (0.53) ALDH1A1KDM4ELMNAHPGDTDP1
SCHEMBL29975243 0.83 ALDH1A1 (0.53) ALDH1A1KDM4ELMNAHPGDTDP1
SCHEMBL9128320 0.82 ALDH1A1 (0.41) ALDH1A1KDM4ELMNAHPGDTDP1
SCHEMBL6889978 0.81 ALDH1A1 (0.51) ALDH1A1KDM4ELMNAHPGDTDP1
SCHEMBL4715285 0.81 ALDH1A1 (0.55) ALDH1A1KDM4ELMNAHPGDTDP1
SCHEMBL4146683 0.81 ALDH1A1 (0.51) ALDH1A1KDM4ELMNAHPGDTDP1
SCHEMBL5681342 0.81 ALDH1A1 (0.51) ALDH1A1KDM4ELMNAHPGDTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250179043-A1 PROCESSES FOR THE PREPARATION OF N-(1-METHYLCYCLOPROPYL)-2-(3-PYRIDINYL)-2H-INDAZOLE-4-CARBOXAMIDE AND INTERMEDIATES THEREOF FMC CORP (US) 2025-06-05 US disclosed
US-20250163010-A1 PROCESSES FOR THE PREPARATION OF N-(1-METHYLCYCLOPROPYL)-2-(3-PYRIDINYL)-2H-INDAZOLE-4-CARBOXAMIDE AND INTERMEDIATES THEREOF FMC CORP (US) 2025-05-22 US disclosed
US-20250154124-A1 PROCESSES FOR THE PREPARATION OF N-(1-METHYLCYCLOPROPYL)-2-(3-PYRIDINYL)-2H-INDAZOLE-4-CARBOXAMIDE AND INTERMEDIATES THEREOF FMC CORP (US) 2025-05-15 US disclosed
WO-2023158769-A1 PROCESSES FOR THE PREPARATION OF N-(1- METHYLCYCLOPROPYL)-2-(3 -PYRIDINYL)-2H- INDAZOLE-4-CARBOXAMIDE AND INTERMEDIATES THEREOF FMC CORPORATION (US) 2023-08-24 WO disclosed
EP-2432776-B1 METHYL SULFANYL PYRIMIDINES USEFUL AS ANTIINFLAMMATORIES, ANALGESICS, AND ANTIEPILEPTICS UNIV LAVAL (CA) 2019-09-11 EP disclosed
WO-2018138692-A1 NOVEL FUNGICIDAL CARBAMATE COMPOUNDS INSECTICIDES (INDIA) LIMITED (IN) 2018-08-02 WO disclosed
US-9796726-B2 Dihydroquinoline pyrazolyl compounds HOFFMANN-LA ROCHE INC. (US) 2017-10-24 US disclosed
US-9796702-B2 Dihydroquinoline pyrazolyl compounds HOFFMANN-LA ROCHE INC. (US) 2017-10-24 US disclosed
US-9790200-B2 Dihydroquinoline pyrazolyl compounds HOFFMANN-LA ROCHE INC. (US) 2017-10-17 US disclosed
EP-3212630-A1 NEW DIHYDROQUINOLINE PYRAZOLYL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2017-09-06 EP disclosed
EP-1227090-A1 AMINE DERIVATIVES Tadeka Chemical Industries, Ltd. (JP) 2002-07-31 EP disclosed
EP-1192121-A1 METHOD FOR PRODUCING 2-HALO-6-NITROBENZOIC ACIDS Bayer Aktiengesellschaft (DE) 2002-04-03 EP disclosed
WO-2000076951-A1 METHOD FOR PRODUCING 2-HALO-6-NITROBENZOIC ACIDS BAYER AKTIENGESELLSCHAFT (DE) 2000-12-21 WO disclosed
CN-1094044-A Imidazopyridine MERCK PATENT GMBH (DE) 1994-10-26 CN disclosed
US-4692182-A Herbicidal isoxazolidinone derivatives FMC CORPORATION (US) 1987-09-08 US disclosed
US-4390540-A ANTICOAGULANTS HOFFMANN-LA ROCHE INC. (US) 1983-06-28 US disclosed
EP-0000718-B1 QUINAZOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS AND THEIR PREPARATION F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1982-03-24 EP disclosed
EP-0046267-A1 Imidazoquinazoline derivatives, their preparation and pharmaceutical compositions containing them F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1982-02-24 EP disclosed
US-4256748-A INOTROPIC AGENTS HOFFMANN-LA ROCHE INC. (US) 1981-03-17 US disclosed
EP-0000718-A2 Quinazoline derivatives, process for their preparation, pharmaceutical preparations and their preparation F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1979-02-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250179043-A1 PROCESSES FOR THE PREPARATION OF N-(1-METHYLCYCLOPROPYL)-2-(3-PYRIDINYL)-2H-INDAZOLE-4-CARBOXAMIDE AND INTERMEDIATES THEREOF ACHE, CYP4B1, CYP3A4 ALDH1A1 1130/4885KDM4E 1170/4885LMNA 402/4885
US-20250154124-A1 PROCESSES FOR THE PREPARATION OF N-(1-METHYLCYCLOPROPYL)-2-(3-PYRIDINYL)-2H-INDAZOLE-4-CARBOXAMIDE AND INTERMEDIATES THEREOF ACHE, CYP4B1, CYP3A4 ALDH1A1 1130/4885KDM4E 1170/4885LMNA 402/4885
US-20250163010-A1 PROCESSES FOR THE PREPARATION OF N-(1-METHYLCYCLOPROPYL)-2-(3-PYRIDINYL)-2H-INDAZOLE-4-CARBOXAMIDE AND INTERMEDIATES THEREOF ACHE, CYP4B1, CYP3A4 ALDH1A1 1130/4885KDM4E 1170/4885LMNA 402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.